Drugs / brimonidine tartrate/timolol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01229462 | Oct 2010 → Sep 2011 | glaucoma, ocular hypertension | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brimonidine tartrate/timolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01229462 ↗ |
| Route | Topical | “administered to the affected eye(s)” NCT01229462 ↗ |